MYGN

Myriad Genetics Inc

Price:

27.04

USD

Volume:

394,790.00

United States | Biotechnology

-131.60 %

Upside

As of 2024-09-11, the Fair Value of Myriad Genetics Inc (MYGN) is -8.54 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 27.04 USD, the upside of Myriad Genetics Inc is -131.60%.

Note: valuation result may not be accurate due to the company's negative EPS.

27.04 USD

Stock Price

-8.54 USD

Fair Price

Peter Lynch's formula is:

MYGN Fair Value

= Earnings Growth Rate x TTM EPS
MYGN Fair Value

= 5.00 x -1.71
MYGN Fair Value

= -8.54
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2020-06-30 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | -199.50 | -53.10 | -27.20 | -112.00 | -263.30 | -131.02 |

YoY growth | -4,436.96% | 73.38% | 48.78% | -311.76% | -135.09% | -952.33% |

Market Cap (mil) | 2,455.77 |

P/E | |

Forward P/E |

EPS | -1.71 |

Avg earnings growth rate | -952.33% |

TTM earnings | -155.20 |